Type to search

Alistair Draffan

Alistair Draffan
Chief Executive Officer & Co-founder

Alistair Draffan

• Commercially-focused pharmaceutical R&D: track record of translating innovative science to identify preclinical and clinical drug candidates
• Committed to excellence in people and project management to achieve timely, high-quality, customer-focused delivery
• Leadership of high-performing teams: over 15 years’ responsibility for groups of scientists and experts who consistently produce exceptional results on a global stage
• Strategic management: proactive coordination of business operations and concurrent projects including balancing competing priorities and mitigating risks
• Licensing and collaboration: leading role in successful partnerships with pharmaceutical and biotech companies

Posts Featuring Alistair Draffan

BioAgilytix to Purchase Australia-Based 360biolabs® | Pharmtech Focus

BioAgilytix to Purchase Australia-Based 360biolabs®